by Penghui Hu, Huiyi Li, Zemin Ji, Weijia Jing, Zihan Li, Sujun Yu, Xiao Shan, Yan Cui, Baochen Wang, Hongyuan Dong, Yanzhao Zhou, Zhe Wang, Hui Xiong, Xiaomei Zhang, Hui-chieh Li, Jinrong Wang, Jiuzhou Tang, Ting Wang, Keliang Xie, Yuping Liu, Haizhen Zhu, Qiujing Yu
Fructose-1,6-diphosphate (FBP), a key glycolytic metabolite, is recognized for its cytoprotective effects during stress. However, the role of FBP in viral infections is unknown. Here, we demonstrate that virus-infected cells exhibit elevated FBP levels. Exogenous FBP inhibits both RNA and DNA virus infections in vitro and in vivo. Modulating intracellular FBP levels by regulating the expression of the metabolic enzymes FBP1 and PFK1 significantly impacts viral infections. Mechanistically, the inhibitory effects of FBP are not a result of altered viral adhesion or entry and are largely independent of type I interferon-mediated immune responses; rather, they occur through modulation of HMGB1. During viral infections, FBP predominantly reduces the protein levels of HMGB1 by facilitating its lysosomal degradation. Furthermore, FBP interacts with HMGB1 and disrupts the binding of HMGB1 to viral genomes, thereby further inhibiting viral replication. Our findings underscore the potential of FBP as a therapeutic target for controlling viral infections.